Atlas Trials

A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate

Clinical trial NCT01679951 · TERMINATED

Trial details

NCT number
NCT01679951
Sponsor
Janssen Research & Development, LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2012-10-31
Primary completion
2014-04-17
Enrollment
272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.